Chaedrol's Washington Horizon
  • Home
  • Chaedrol solutions
  • GWAC tracker
  • Acquisition
  • Travel
  • Contact us
  • Social media
Sign in Subscribe

GLP-1 drugs

GLP‑1 drug’s rare gastric obstruction dissolved with Diet Coke

GLP‑1 drug’s rare gastric obstruction dissolved with Diet Coke

A case study in the New England Journal of Medicine, as reported by Ars Technica, highlights a rare side effect of GLP‑1 therapy—formation of a gastric bezoar—successfully treated with diet cola. In the case, a 63‑year‑old patient taking semaglutide for weight loss presented with severe
Jason Lee Bakke Sep 26, 2025
Employers balk at cost of Ozempic as pressure builds for weight-loss drug coverage

Employers balk at cost of Ozempic as pressure builds for weight-loss drug coverage

The next flashpoint in employer-sponsored health benefits is here: whether companies should foot the bill for blockbuster weight-loss drugs like Ozempic. As the Wall Street Journal reports, firms are split over the cost-benefit calculus of covering GLP-1 medications, with many limiting access or cutting coverage altogether. The decision carries weight—
Jason Lee Bakke Apr 2, 2025

Subscribe to Chaedrol's Washington Horizon

Don't miss out on the latest news. Sign up now to get access to the library of members-only articles.
  • Government acquisition I/O
  • Travel news and analysis
  • AI-enabled GAO protest log
  • Submit a tip
Chaedrol's Washington Horizon © 2025. Powered by Ghost